Diverse by nature – experts by design
Drug candidates in the development pipeline are increasingly innovative and complex. As your CDMO of choice, we will use our industry-leading expertise and track record and ambition to accelerate your path to the clinic or commercialization for mammalian, microbial, or bioconjugates.
Active at Every Stage
We offer end-to-end services from pre-clinical through to commercialization, for drug substance and drug product across all modalities
Expression options for your evolving needs
To accelerate production, developers need efficient and regulatory-compliant expression systems that scale quickly and reproducibly to meet future needs. Our portfolio of mammalian and microbial expression platforms are available for use in your lab under license, or at Lonza under a service agreement.
The right location; the right scale
We continuously invest to expand our global network to serve you where you need it.
Biologics